Internship

Clinical Operations Summer Intern

Posted on 12/20/2024

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulators for medical conditions

Biotechnology
Healthcare

Compensation Overview

$25 - $31Hourly

No H1B Sponsorship

San Carlos, CA, USA

Must work at the Redwood City office for the duration of the internship, no relocation available.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Must be currently enrolled as a full-time student in an accredited US-based university or college
  • Completed college science courses
  • Must be able to complete at least 10 consecutive weeks between June and August and it is a full-time internship (40 hours per week)
  • Must be able to work at our Redwood City office for the duration of the internship, no relocation available
  • Proficient in Microsoft Outlook, Word & Excel
  • Energetic, result-driven, self-starter with the ability to work in a highly collaborative environment
  • Good organizational and communication skills
  • Able to perform detailed work accurately and in a timely manner
Responsibilities
  • Assist project team with study-specific documentation, including filing to the Clinical Trial Management System and Trial Master File
  • Maintain Trial Master File by setting up and using tracking tools
  • Facilitate submission of regulatory documents to/for a central institutional review board (IRB) and coordinate collection, tracking, and maintenance of updated site regulatory documentation
  • Track clinical supply inventory at sites and manage the site drug re-supply process
  • Other Duties as assigned
  • Assist in the preparation and review of study meeting material
  • Work with other functional areas as directed to complete tasks
  • Track and update project status information using spreadsheets and other systems
  • Deliver a department presentation at the end of the program
  • Participate as a member of the 2025 intern team group project that includes a company-wide presentation

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Company Stage

IPO

Total Funding

$42.6M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

23%

1 year growth

31%

2 year growth

49%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in cortisol modulation for mental health expands Corcept's market potential.
  • Advancements in biomarker discovery enhance the effectiveness of Corcept's treatments.
  • The rise of personalized medicine offers opportunities for targeted therapies by Corcept.

What critics are saying

  • Teva's antitrust lawsuit could lead to significant legal expenses for Corcept.
  • Roberto Vieira's appointment may divert resources from Corcept's core focus on cortisol.
  • Recent stock offering may dilute shareholder value, indicating potential financial challenges.

What makes Corcept Therapeutics unique

  • Corcept specializes in cortisol modulation, a niche with few direct competitors.
  • Their flagship product, Korlym, is the first FDA-approved treatment for Cushing's syndrome.
  • Corcept has discovered over 1,000 selective cortisol modulators, showcasing strong R&D capabilities.

Help us improve and share your feedback! Did you find this helpful?